Skip to main content
All lobbying filings

The Conafay Group, LLC

The Conafay Group, LLC filed a Q2 report for Cresilon, Inc. on July 20, 2026, reporting $10,000 in lobbying income.

Lobbying for Cresilon, Inc. · Pharmaceutical Company

As filed: THE CONAFAY GROUP, LLC for CRESILON, INC.

All filings by The Conafay Group, LLC · Everything Cresilon, Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
New York

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Support for hemostatic technology research and the manufacturing of hemostatic products.

Support for hemostatic technology research and the manufacturing of hemostatic products.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem